News Winter Collaboratorium to Connect Students, Scientists Showcasing a Range of Innovations The winter Collaboratorium will connect innovators from UChicago Medicine, the Physical Sciences Division, and Argonne’s Chain Reaction Innovations program with University of Chicago students. The Collaboratorium provides the opportunity for...
News Polsky Center I-Corps Teams Test Commercialization Potential of Research The Polsky I-Corps program helps scientists, researchers, and students test the commercial potential of their research and ideas. Supported with funding from the National Science Foundation (NSF) through the Great...
News UChicago Researchers Isolate Antibodies to Treat and Diagnosis COVID-19, Work to Protect Against Future Threats University of Chicago researchers have isolated SARS-CoV-2 monoclonal antibodies, which have the potential to both treat and diagnose COVID-19. Led by Patrick Wilson, a professor of medicine at the University...
Technology SARS-CoV-2 Monoclonal Antibodies Against Spike and Internal Proteins for Therapeutics and Diagnostics As of February 2021, there have been over 107 million cases and over 2 million deaths caused worldwide by the novel virus SARS-CoV-2. Few vaccination and treatment approaches are currently…
Technology Broadly Neutralizing Neuraminidase Antibodies for Prophylactic and Therapeutic Treatment of Influenza One of the weaknesses of current influenza vaccines is seasonable variability in efficacy, which is predominantly caused by escape mutations in the hemagglutinin (HA) antigen, the main target of the…
Technology Neutralizing Monoclonal Antibodies Against SARS-CoV-2 The landscape of SARS-CoV-2 is experiencing a novel development of viral variants harboring mutations that can escape even the most highly potent antibodies against the receptor binding domain. These variants…
Technology A Novel Class of Antibodies For The Development Of Universal Influenza Vaccines Influenza viruses remain a global health problem, with antigenically drifting seasonal viruses and the constant risk of zoonotic influenza virus spillovers into humans. Antibodies against the major surface glycoprotein hemagglutinin…
Program Collaboratorium Showcase your research, technology, or ideas and develop a better understanding of the next steps to pursue a business opportunity.
News Fall 2025 Collaboratorium Connects Researchers and Business Expertise Connecting researchers and scientists with business expertise, the Fall 2025 Collaboratorium will feature teams participating in the Polsky I-Corps program in addition to startups from other areas of the...
News Home Chef, Remote Year Founders Among Winners at EY’s Entrepreneur of the Year Awards Two notable Chicago startup founders were just given a big nod for their entrepreneurial endeavors. Patrick Vihtelic, founder and CEO of Home Chef, and Greg Caplan, founder and CEO of Remote Year,...
News Polsky Center Announces Autumn 2018 I-Corps Program Cohort The Polsky Center for Entrepreneurship and Innovation is pleased to announce the latest cohort of the Polsky I-Corps program, a 7-week highly-experiential program designed to empower UChicago scientists, researchers, and...
News George Shultz Innovation Fund Invests $600,000 in Biotech Companies The Fall Finals took place on Thursday, December 6.
